a b s t r a c t Background: As a result of the focus on vital functions in patients with brain damage, dermatological symptoms are often overlooked during their period of admission to hospital. However, patients with brain damage are more likely to have dermatological diseases than the general population and other inpatients for various reasons, including immobilization, treatment with multiple drugs, long-term hospitalization, and their immunocompromised status. Objectives: The purposes of this study were: (1) to analyze the frequency and characteristics of dermatological consultations among patients who were admitted to hospital as a result of brain damage; and (2) to compare these findings with other reports about inpatient dermatological consultations. Methods: We analyzed data for 240 patients with brain damage who attended our department of dermatology between January 1, 2007 and December 31, 2011. The total numbers of male and female patients were 132 (55%) and 108 (45%), respectively (male to female ratio 1.22:1). We retrospectively reviewed medical records, demographic information, reason for dermatological consultation, and the diagnosis of the dermatoses. Results: The age group most frequently seen was patients in the 7 th decade of life and the most common underlying brain injury was traumatic intracranial hemorrhage. The mean AE standard deviation score on the Glasgow Coma Scale (GCS) was 6.8 AE 3.0. When the levels of brain damage of the patients were classified using the GCS, 68.3% of the patients were in the severe (GCS 8) category. The most common skin disorders were seborrheic dermatitis (17.9%), followed by mycoses (15.5%), and drug-induced skin eruption (13.2%).
Introduction
Although the practice of dermatology has recently become a predominantly outpatient-based specialty, there continues to be a need for dermatological expertise within hospitals, where patients have a wider spectrum of severe and serious dermatological disorders associated with significant morbidity. 1, 2 Many patients who are admitted to hospital for various nondermatological diseases often have underlying skin disease, whereas others develop acute dermatological problems during their stay in hospital. These general illnesses contribute to developing and worsening the primary dermatological diseases; the management of an underlying disease can also cause dermatological disease.
Patients with brain damage due to various causes, such as intracranial hemorrhage, hypoxia, metabolic disease, infection, or tumor, may have many dermatological problems, but these are often overlooked during their stay in hospital because of many other complicated medical problems. However, it is still important for doctors to have a consultation with patients with brain damage regarding their skin problems. Such patients are especially vulnerable to druginduced skin eruptions or infections due to the administration of many different drugs and exposure to immunocompromised conditions including underlying disease and long term steroid use.
Several recent studies have independently shown that our skin is an unexpectedly prominent target organ for numerous neuroendocrine, neurotrophic, neurotransmitter, and neuropeptide signals, which have a profound effect on skin biology in health and disease. 3 The aim of this study was to characterize the profiles of patients with brain damage and the scope and referral pattern of Conflicts of interest: The authors declare that they have no financial or nonfinancial conflicts of interest related to the subject matter or materials discussed in this article.dermatology consultations in a tertiary hospital, which has not previously been well studied.
Patients and methods
All consultations with patients in hospital were referred to the Department of Dermatology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea, between 1 January, 2007 and 31 December, 2011. The data were collected retrospectively from the admission and daily progression notes provided by the attending doctor and the consultation notes made by the dermatological consultant. Final diagnoses were classified according to the English version of the International Statistical Classification of Diseases and Related Health Problems (ICD-10). 4 Only the dermatological disorder responsible for the consultation was recorded. During weekdays, each request was allocated to one of three different dermatology consultants, assisted by a 3 rd -year dermatology resident. A potassium hydroxide smear test from skin scrapings, swabs for bacterial culture, and biopsy samples were taken as appropriate by the dermatologist to reach a definitive diagnosis. The severity of brain damage was classified into three groups (severe, moderate, and mild) based on the Glasgow Coma Scale (GCS) and these scores were evaluated by the attending doctors.
All statistical analyses were performed using SPSS 12.0 (SPSS Inc., Chicago, IL, USA). Absolute and relative frequencies were analyzed for all data. Continuous variables, such as age, were expressed as mean values with standard deviations. The difference in the prevalence of skin disease according to the GCS score was evaluated by the Chi-square test. In all instances, p < 0.05 was considered significant.
Results
During the 5-year study period, 240 patients who presented with altered consciousness due to brain damage were referred to the dermatologists. We diagnosed 341 dermatological diseases, performed 45 skin biopsies, 11 bacterial cultures, 67 potassium hydroxide smear tests, and 13 dermatological procedures of various kinds (cryotherapy, intralesional injection, and wet dressing). Ninety-five patients (39.6%) were seen twice by a dermatologist for different dermatological symptoms. The most frequent age group was the patient's 7 th decade of life (25.3%) and the next most frequent was the 6 th decade (19.5%) ( Table 1 ).
The most frequent cause of brain damage was traumatic intracranial hemorrhage (50.4%), followed by spontaneous intracranial hemorrhage (28.7%), hypoxia (10.4%), metabolic disease (4.6%), infectious disease (2.9%), and brain tumors (2.6%) ( Table 2 ). The most frequent diagnosis was seborrheic dermatitis (ICD-10:L21; 17.9%), mycoses (ICD-10:B35w37; 15.5%), drug-induced skin eruption (ICD-10:L27.0, 27.1; 13.2%), xerosis cutis (ICD-10:L85.3; 9.1%), irritant contact dermatitis (ICD-10:L24; 5.3%), and pruritus (ICD-10:L29; 4.4%) ( Table 3) . It took a mean of 39.4 days for seborrheic dermatitis to become symptomatic and for the patient to be seen by a dermatologist after initial brain damage, 31.4 days for mycoses, 15.0 days for drug-induced skin eruption, and 47.1 days for xerosis cutis.
Based on the level of brain damage using the GCS, 68.3% of patients were at the severe (GCS 8) level (Table 4 ). The most common dermatological diseases in the severe group were mycoses (24.9%), seborrheic dermatitis (20.6%), and drug-induced skin eruption (18%). For the 25.5% of patients in the moderate (9 GCS 12) group, the common diseases were seborrheic dermatitis (20.6%), pruritus (13.8%), and drug-induced skin eruption (12.6%). For the 6.2% of patients in the mild (GCS ! 13) group, the common diseases were seborrheic dermatitis (28.6%), pruritus (14.3%), and herpes simplex (14.3%). The incidence of mycoses is statistically significantly higher in the severe group (p < 0.01).
Discussion
The dermatological diseases of patients with brain damage are often overlooked during their period of admission to hospital because of many other complicated medical problems. Patients with brain damage have difficulty in describing their symptoms because of an alteration in consciousness, and this tends to delay diagnosis. However, we should also consider the fact that the opportunity to develop dermatological problems is relatively high in patients with brain damage. Decreased movement, altered immunity, and long-term stays in hospital provide suitable conditions for the growth of microorganisms, and treatment with antibiotics or aromatic anticonvulsant drugs (e.g. carbamazepine, phenytoin, phenobarbital, primidone, and oxcarbazepine) can cause severe adverse drug reactions. In particular, a recent study has shown that the central nervous system and the skin are connected by various mechanisms. 3 The fact that the skin and nervous system develop from the same embryological origin, share common molecular syntax, and communally utilize the immune system to provide signals and regulation, is generally acknowledged. 3, 5 The central nervous system is directly or indirectly connected to the functioning of skin. 5 The direct connection is via efferent nerves or mediators derived from the central nervous system, and the indirect connection is via the adrenal glands or immune cells. 5 We thus speculate that damage of the central nervous system can contribute to the development of dermatological diseases. In our study, 68.3% of the patients who were seen by a dermatologist had a severe alteration of consciousness. We believe that dermatological disease is likely to occur when a patient's brain damage is severe. The severe brain damage can cause immobilization. In addition, the patients with more severe brain damage tend to be treated with a larger number of drugs, such as anticonvulsant drugs, antibiotics, and diuretics.
The most frequent diagnosis was seborrheic dermatitis in 17.9% of the patients. Previous reports for a diagnosis of seborrheic dermatitis ranged from 3.1% to 5.2% of patients referred to a dermatologist. 2, 6 It has long been recognized that patients with
Parkinson's disease and mood disorder who have been treated with neuroleptic drugs often develop seborrheic dermatitis. 7 The organic change of the central nervous system due to brain injury may result in changes in various neuromediators and aggravate dermatitis. Furthermore, using various neuroleptic drugs in patients with brain damage can cause and worsen seborrheic dermatitis.
The second most frequent diagnosis in these patients was mycoses (15.5%) and the incidence was significantly higher in the group with severe brain injury (p < 0.01). This is most likely to be induced by a prolonged period of being confined to bed and the treatment of patients with brain damage with multiple antibiotic drugs. 8, 9 A previous study reported that 9.5% of dermatology consultations were requested for mycosis. 2 The median time between admission to hospital (with consequent immobilization in bed) and the consultation for mycoses was 31.4 days (range 12e85 days). In a previous study for decubitus candidiasis, the median time was 24.8 days. 9 In our study, 13.2% of the patients were diagnosed with skin eruption due to treatment with drugs. The prevalence of druginduced skin eruption is higher here than in a previous study, which ranged from 4.2% to 10.5%.
2 This is because patients with 10 It is widely accepted that the latent period of a drug reaction is approximately 2e6 weeks (mean 2e4 weeks). 11 The mean latency of drug-induced skin eruption was 15 days (range 3e45 days) in our study.
Another common disorder in our study was xerosis cutis, which occurred in 9.1% of patients. The incidence is higher than previous studies of consultations with inpatients (2.8%). 1, 2, 6 Xerosis is more common in elderly patients and the mean AE SD age of our patients with xerosis cutis was 76.5 AE 5.1 years. Elderly patients are more susceptible to xerosis due to pre-existing disease states, treatments, and prescribed drugs. Some of these pre-existing conditions include radiation, end-stage renal disease, nutritional deficiency (especially zinc and essential fatty acids), thyroid disease, and neurological disorders with decreased sweating, treatment with antiandrogen drugs, treatment with diuretics, human immunodeficiency virus, and malignancies. Multiple individual factors may contribute to xerosis cutis. This study has a limitation in that many of the diagnoses were performed only by clinical impression without taking a skin biopsy sample or fungus culture. Also a computed tomography scan is preferable to the GCS in evaluating the severity of brain damage. Most of the patients included in our study were in the acute stage of brain damage. Over the past few years, several studies have repeatedly shown that bullous pemphigoid is associated with chronic neurological diseases, such as cerebrovascular disease, dementia, multiple sclerosis, and Parkinson's disease. 12e16 It is thought that bullous pemphigoid antigens or their isoforms in the central nervous system may be exposed after a neurological insult and may contribute to the generation of an immune response. 17 However, our study did not study long-term dermatological problems in the chronic stages of brain damage and did not analyze any molecular or immunological link between dermatological problems and neurological diseases. It was also unclear whether some patients had a past history of dermatological disease, such as seborrheic dermatitis, tinea pedis, or xerosis cutis. However, this study does provide the information that dermatological disorders in patients with brain damage may become symptomatic and require a consultation with a dermatologist.
In conclusion, we suggest that patients with brain damage are more likely to have dermatological diseases than both the general population and inpatients in general. This is due to various reasons, such as immobilization, treatment with multiple drugs, long-term stays in hospital, and their immunocompromised status. Furthermore, brain damage and its treatment can release steroid hormones and alter neuromediators, leading to an abnormal immune response and an aggravating inflammatory response in the skin. Although the exact mechanism has not been shown, the analysis of dermatological disorders in patients with brain damage can provide a better understanding of the "braineskin connection". 
